Clinical Trial Update: POC HIV Testing and Early DTG Use for Infants [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates point-of-care HIV testing and early dolutegravir use in infants. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir) (dolutegravir)

Snippet

Sponsor: Harvard School of Public Health (HSPH) | Conditions: HIV | Phase 4 | Status: ACTIVE_NOT_RECRUITING